New cellular therapy approved for type 1 diabetes called Lantidra.

[Amity Island]

Lantidra is an allogeneic (donor) pancreatic islet cellular therapy. In other words, Lantidra uses cells taken — or isolated — from human organ donor pancreases.

“In the process, the donated pancreas is digested in a special chamber using specific enzymes that allow [it] to break the islets out of their natural environment,”

Type 1 diabetes: New cell therapy reduces need for insulin

The FDA has recently approved a cellular therapy for type 1 diabetes for the first 1. The therapy, called Lantidra, can reduce the need for insulin injections.

www.medicalnewstoday.com

 

[mikeyB]

Yes, but the problem is rejection of the graft, so immunosuppressive drugs have to be taken. This, of course, leaves the patient to acquire every bug that is doing the rounds.

Faced with that, taking insulin is far less trouble. And make it extremely unlikely too get approval from NICE because of the cost of immunosuppressive drugs for life, just to avoid taking pain free injections.

 

[Amity Island]

Yes, but the problem is rejection of the graft, so immunosuppressive drugs have to be taken. This, of course, leaves the patient to acquire every bug that is doing the rounds.

Faced with that, taking insulin is far less trouble. And make it extremely unlikely too get approval from NICE because of the cost of immunosuppressive drugs for life, just to avoid taking pain free injections.

On that basis, probably only feasible for those where the benefit is greater than risks.